Stay updated on Optune in Melanoma Brain Mets + Immune Checkpoint Inhibitors Clinical Trial
Sign up to get notified when there's something new on the Optune in Melanoma Brain Mets + Immune Checkpoint Inhibitors Clinical Trial page.

Latest updates to the Optune in Melanoma Brain Mets + Immune Checkpoint Inhibitors Clinical Trial page
- Check2 days agoChange DetectedThe page’s version/revision indicator has been updated from v3.5.2 to v3.5.3, reflecting a site software release rather than a change to the study record content.SummaryDifference0.1%

- Check9 days agoChange DetectedUpdated revision from v3.5.0 to v3.5.2.SummaryDifference0.1%

- Check16 days agoNo Change Detected
- Check38 days agoChange DetectedSite revision change: v3.4.3 was removed and v3.5.0 added.SummaryDifference0.1%

- Check45 days agoChange DetectedRevision tag updated from v3.4.2 to v3.4.3 on the page.SummaryDifference0.1%

- Check73 days agoChange DetectedRevision: v3.4.2 was applied and an older funding notice was removed; these are maintenance updates that do not change trial details on the page. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check81 days agoChange DetectedAdded a government funding status notice and a new revision label (v3.4.1); these changes do not alter study details, results, or enrollment information. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

Stay in the know with updates to Optune in Melanoma Brain Mets + Immune Checkpoint Inhibitors Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Optune in Melanoma Brain Mets + Immune Checkpoint Inhibitors Clinical Trial page.